Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin‐induced thrombocytopenia
- 3 September 2002
- journal article
- case report
- Published by Wiley in American Journal of Hematology
- Vol. 71 (1) , 50-52
- https://doi.org/10.1002/ajh.10181
Abstract
We report two patients with deep‐vein thrombosis complicating immune heparin‐induced thrombocytopenia who developed venous limb gangrene during overlapping therapy with a direct thrombin inhibitor (lepirudin or argatroban) and warfarin. In both patients, therapy with the direct thrombin inhibitor was interrupted during persisting severe athrombocytopenia while warfarin administration continued. Both patients exhibited the typical feature of a supratherapeutic international normalized ratio (INRs, 5.9 and 7.3) that has been linked previously with warfarin‐associated venous limb gangrene. These data suggest that warfarin anticoagulation be postponed in patients with acute heparin‐induced thrombocytopenia until substantial recovery of the platelet count has occurred. Am. J. Hematol. 71:50–52, 2002.Keywords
This publication has 6 references indexed in Scilit:
- Venous Limb Gangrene during Warfarin Treatment of Cancer-Associated Deep Venous ThrombosisAnnals of Internal Medicine, 2001
- Erratum for vol. 97, p. 2574Blood, 2001
- Laboratory testing for heparin-induced thrombocytopenia.Journal of Thrombosis and Thrombolysis, 2000
- Multicentric warfarin-induced skin necrosis complicating heparin-induced thrombocytopeniaAmerican Journal of Hematology, 1999
- The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced ThrombocytopeniaAnnals of Internal Medicine, 1997
- Heparin-Induced thrombocytopenia: IgG-Mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-Induced thrombocytopeniaTransfusion Medicine Reviews, 1996